Report Content
Chapter 1 Methodology
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Serum-free media industry 360º synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Type trends
2.1.4 Application trends
2.1.5 End-user trends
Chapter 3 Serum-free Media Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing adoption of cell culture technologies for cell-based vaccines
3.2.1.2 Rising prevalence of infectious and chronic diseases
3.2.1.3 Rising R&D investments to develop novel regenerative therapies and disease specific solutions
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent regulatory guidelines
3.3 Growth potential analysis
3.3.1 By type
3.3.2 By application
3.3.3 By end-user
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Serum-free Media Market, By Type, 2018 - 2032 (USD Million)
5.1 Key trends, by type
5.2 CHO cell culture
5.3 Protein expression media
5.4 Stem cell media
5.5 Immunology media
5.6 Hybridoma media
5.7 Other media types
Chapter 6 Serum-free Media Market, By Application, 2018 - 2032 (USD Million)
6.1 Key trends, by application
6.2 Biopharmaceutical production
6.3 Tissue engineering & regenerative medicine
6.4 Stem cell research & therapy
6.5 Other applications
Chapter 7 Serum-free Media Market, By End-user, 2018 - 2032 (USD Million)
7.1 Key trends, by end-user
7.2 Biopharmaceutical companies
7.3 Clinical research organizations
7.4 Academic research centers
Chapter 8 Serum-free Media Market, By Region, 2018 - 2032 (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 MEA
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 Rest of MEA
Chapter 9 Company Profiles
9.1 Sartorius AG
9.2 Thermo Fisher Scientific Inc.
9.3 Merck KGaA
9.4 FUJIFILM Irvine Scientific, Inc.
9.5 Lonza Group
9.6 MP Biomedicals
9.7 Corning Incorporated
9.8 PAN-Biotech
9.9 R&D Systems
9.10 PromoCell GmbH
